Primary focus
L2 Advancing Investigators
Qualified physicians building deeper research experience, publications and scientific contributions.
- Readiness and training
- Study activation and operations
- L1 mentors may support scientific development
UNITY SITE NETWORK Part of the CMBH research platform
Physician-Led Research Site Development.
Physician-Led Site Development. Investigator Mentorship. Coordinated Clinical Research.
What Unity is
The site-development and coordination network
Unity Site Network is the research-site development and coordination network within the CMBH Clinical Research platform. It is designed to help independent physician practices develop research capabilities, connect with suitable clinical studies, and participate in a consistent, high-quality research operating framework.
Physician leadership
Vipul Dev, MD
Board-certified plastic surgeon and principal investigator, Bakersfield, California. Physician leader, Unity Site Network.
Dr. Dev leads Unity's site-development strategy and oversees day-to-day operations across participating sites. He manages other physicians at multiple sites and has experience running multi-site clinical trial operations, including work alongside SerenaGroup.
- Leads site development and physician onboarding
- Manages physician investigators across multiple sites
- Collaborates with senior research leaders and the technical partner
Operating model
Who Unity is built for
Primary focus
L3 Emerging Research Sites
Practices interested in becoming qualified research sites.
- Readiness assessment and guidance
- Training and study-specific support
- Some may begin as referral-only, without trial-site duties
Selective focus
L1 Distinguished Investigators
Experienced research leaders whose sites may use Unity coordination.
- May mentor L2 and L3 colleagues
- May lead multi-site programs
Unity coordinates site operations and physician development. Each trial site still requires its own appropriately qualified investigator, who keeps protocol-specific regulatory and clinical duties. An L1 lead investigator does not automatically replace the investigator of record at other sites. L1, L2 and L3 are CMBH program designations, not FDA classifications. Applying does not mean automatic site acceptance or guaranteed study allocation.
Proposed capabilities
What Unity is intended to provide
Site qualification
Readiness assessments.
Investigator onboarding
Onboarding and GCP training coordination.
Startup and activation
Startup and activation support.
Feasibility
Protocol feasibility and patient-population matching.
Coordination
Coordinator and workflow support where contracted.
Standard practices
Standardized operating practices and quality escalation.
Reporting
Site performance and enrollment reporting.
Mentoring
Mentoring relationships with L1 investigators.
Status. These are proposed capabilities of a network in development. Nothing here means a site is active or a study is enrolling.